Radium-223 Dichloride Asian Population Study in the Treatment of CRPC Patients With Bone Metastasis
Status:
Completed
Trial end date:
2017-09-25
Target enrollment:
Participant gender:
Summary
To evaluate the safety and efficacy (Overall survival [OS]) of multiple doses of Ra-223
dichloride in an Asian population of subjects with CRPC metastatic to the bone.